NASDAQ
SeaStar Medical Holding Corporation (ICU)
♥ 431 Thanks from members
SeaStar Medical Holding Corporation (ICU) displays a high-risk, micro-cap biotechnology profile characterized by expanding commercial adoption of its QUELIMMUNE therapy for pediatric AKI, rising clinical trial expenses, ongoing net losses, and micro-cap stock volatility, including a recent 1-for-10 reverse stock split.